FDA Approves Medtronic MiniMed 630G

Medtronic Minimed 630G System

The U.S. FDA has approved Medtronic’s new MiniMed 630G system with SmartGuard technology. This Minimed 630G system provides better glucose control, protective action and personalized management so people with diabetes can focus less on managing diabetes and more on what matters most … Read more

FDA Approves Adlyxin, Sanofi’s New Type 2 Diabetes Drug 

Sanofi Logo

The U.S. FDA approved Sanofi’s new diabetes drug, Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels) in adults with type 2 diabetes. Adlyxin is a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalize blood … Read more

FDA Approves t:slim Insulin Pump for Children Ages 6 and Older

From Shots to Tandem t:slim Pump

The U.S. FDA has approved Tandem Diabetes Care’s t:slim Insulin Pump for use by children age 6 and older. Until now the t:slim Insulin Pump was approved for use by children age 12 and older. This expanded pediatric indication applies to the current t:slim Pump features, with … Read more

New Medtronic Guardian Connect Mobile CGM System Approved in EU

Medtronic Guardian Connect

Medtronic has received CE (Conformité Européenne) Mark for its new Guardian Connect mobile continuous glucose monitoring (CGM) system for people with diabetes using insulin injection therapy. Guardian Connect is the first smartphone-enabled CGM system from Medtronic to receive CE Mark and … Read more

FDA Advisory Committee Votes To Approve IDegLira


The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the approval of Novo Nordisk’s IDegLira for the treatment of adults with type 2 diabetes.  IDegLira is a once-daily, single injection fixed combination … Read more

FDA Announces New Nutrition Label

New Nutrition Labels - 2016 - Home

Today the U.S. Food and Drug Administration (FDA) announced a new Nutrition Facts label for most packaged foods that reflects the latest in nutrition science including the link between diet and chronic diseases such as obesity and heart disease. The new … Read more

Invokana May Increase Risk of Leg and Foot Amputations

Invokana Pill Box

The FDA issued a safety communication alerting the public about interim safety results from an ongoing clinical trial that found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with the diabetes medicine canagliflozin (Invokana, Invokamet). … Read more

Subscribe to our Newsletter

Hide me